or Try an Advanced Search...

    Technical Analysis for ONCY - Oncolytics Biotech Inc.

    Grade Last Price % Change Price Change
    B 1.14 -3.39% -0.04
    ONCY closed down 3.39 percent on Monday, November 4, 2024, on 53 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical ONCY trend table...
    Date Alert Name Type % Chg
    New Downtrend Bearish 0.00%
    Golden Cross Bullish 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Earnings Movers Other 0.00%
    Gapped Down Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.39%
    Earnings Movers Other -3.39%
    1,2,3 Pullback Bullish Bullish Swing Setup -0.87%
    Older End-of-Day Signals for ONCY ...

       Recent Intraday Alerts

    Alert Time
    Gap Down Closed about 18 hours ago
    Reversed from Down about 19 hours ago
    60 Minute Opening Range Breakout about 19 hours ago
    Gapped Down (Full) about 20 hours ago
    Down 5% about 20 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ONCY Chart by TradingView
    Basic chart:

    Profile

    Oncolytics Biotech Inc is a development stage biopharmaceutical company. It is engaged in the discovery and development of pharmaceutical products for the treatment of cancer that have not been successfully treated with conventional therapeutics.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Treatment Of Cancer Pharmaceutical Products Oncolytics Biotech Synbio

    Is ONCY a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 7 ONCY Stock Up on Regulatory Update From Breast Cancer Program
    Oct 7 Oncolytics targets accelerated approval for oncolytic virus therapy
    Oct 4 Oncolytics Biotech® Announces Key Progress and Upcoming Studies for Breast and Pancreatic Cancer Treatments, Prepares for FDA Accelerated Approval Path
    Sep 19 Oncolytics Biotech Reports "Favorable" Results for BRACELET-1 Breast Cancer Study
    Sep 19 Oncolytics Biotech® Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study
    Sep 6 Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September
    Aug 12 Sernova Corp. Announces Appointment of New Chief Executive Officer
    Aug 2 Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 44th Annual Growth Conference
    Aug 1 Oncolytics Biotech Inc. (ONCY) Q2 2024 Earnings Call Transcript
    Aug 1 Oncolytics Biotech GAAP EPS of -$0.10 misses by $0.03
    See more ONCY news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.75
    52 Week Low 0.8401
    Average Volume 474,411
    200-Day Moving Average 1.07
    50-Day Moving Average 1.07
    20-Day Moving Average 1.23
    10-Day Moving Average 1.20
    Average True Range 0.08
    RSI (14) 48.19
    ADX 26.58
    +DI 16.67
    -DI 17.21
    Chandelier Exit (Long, 3 ATRs) 1.28
    Chandelier Exit (Short, 3 ATRs) 1.20
    Upper Bollinger Bands 1.34
    Lower Bollinger Band 1.13
    Percent B (%b) 0.07
    BandWidth 17.13
    MACD Line 0.03
    MACD Signal Line 0.05
    MACD Histogram -0.0219
    Fundamentals Value
    Market Cap 83.67 Million
    Num Shares 73.4 Million
    EPS -0.38
    Price-to-Earnings (P/E) Ratio -3.00
    Price-to-Sales 0.00
    Price-to-Book 3.58
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.23
    Resistance 3 (R3) 1.23 1.21 1.22
    Resistance 2 (R2) 1.21 1.18 1.21 1.21
    Resistance 1 (R1) 1.17 1.17 1.19 1.17 1.20
    Pivot Point 1.15 1.15 1.16 1.15 1.15
    Support 1 (S1) 1.11 1.12 1.13 1.11 1.08
    Support 2 (S2) 1.09 1.11 1.09 1.07
    Support 3 (S3) 1.05 1.09 1.07
    Support 4 (S4) 1.05